These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8617758)

  • 1. Human immunodeficiency virus reverse transcriptase. Functional mutants obtained by random mutagenesis coupled with genetic selection in Escherichia coli.
    Kim B; Hathaway TR; Loeb LA
    J Biol Chem; 1996 Mar; 271(9):4872-8. PubMed ID: 8617758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymatic properties of two mutants of reverse transcriptase of human immunodeficiency virus type 1 (tyrosine 181-->isoleucine and tyrosine 188-->leucine), resistant to nonnucleoside inhibitors.
    Loya S; Bakhanashvili M; Tal R; Hughes SH; Boyer PL; Hizi A
    AIDS Res Hum Retroviruses; 1994 Aug; 10(8):939-46. PubMed ID: 7529032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymatic characterization of human immunodeficiency virus type 1 reverse transcriptase resistant to multiple 2',3'-dideoxynucleoside 5'-triphosphates.
    Ueno T; Shirasaka T; Mitsuya H
    J Biol Chem; 1995 Oct; 270(40):23605-11. PubMed ID: 7559526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of the HIV-1 reverse transcriptase 'AZT-resistant' mutant with substrates and AZT-TP.
    Pokholok DK; Gudima SO; Yesipov DS; Dobrynin VN; Rechinsky VO; Kochetkov SN
    FEBS Lett; 1993 Jul; 325(3):237-41. PubMed ID: 7686510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies of the resistance of the human immunodeficiency virus to azidothymidine. I. Kinetic studies of the interaction between reverse transcriptase and a series of its mutant forms with substrates and azidothymidine-5'-trisphosphate].
    Pokholok DK; Gudima SO; Esipov DS; Dobrynin VN; Memelova LV; Rechinskiĭ VO; Kochetkov SN
    Biokhimiia; 1994 May; 59(5):739-47. PubMed ID: 7519060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of HIV-1 reverse transcriptase and its mutants to inhibition by azidothymidine triphosphate.
    Carroll SS; Geib J; Olsen DB; Stahlhut M; Shafer JA; Kuo LC
    Biochemistry; 1994 Mar; 33(8):2113-20. PubMed ID: 7509634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the amino acid in the human immunodeficiency virus type 1 reverse transcriptase involved in the pyrophosphate binding of antiviral nucleoside triphosphate analogs and phosphonoformate. Implications for multiple drug resistance.
    Im GJ; Tramontano E; Gonzalez CJ; Cheng YC
    Biochem Pharmacol; 1993 Dec; 46(12):2307-13. PubMed ID: 7506027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of two conserved sequence motifs in HIV-1 reverse transcriptase.
    Lowe DM; Parmar V; Kemp SD; Larder BA
    FEBS Lett; 1991 May; 282(2):231-4. PubMed ID: 1709876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic selection in Escherichia coli for active human immunodeficiency virus reverse transcriptase mutants.
    Kim B
    Methods; 1997 Aug; 12(4):318-24. PubMed ID: 9245612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of the reverse transcriptase of human immunodeficiency virus type 1 with DNA.
    Bakhanashvili M; Hizi A
    Biochemistry; 1994 Oct; 33(40):12222-8. PubMed ID: 7522556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutated K65R recombinant reverse transcriptase of human immunodeficiency virus type 1 shows diminished chain termination in the presence of 2',3'-dideoxycytidine 5'-triphosphate and other drugs.
    Gu Z; Arts EJ; Parniak MA; Wainberg MA
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2760-4. PubMed ID: 7535930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infectious potential of human immunodeficiency virus type 1 reverse transcriptase mutants with altered inhibitor sensitivity.
    Larder BA; Kemp SD; Purifoy DJ
    Proc Natl Acad Sci U S A; 1989 Jul; 86(13):4803-7. PubMed ID: 2472634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rapid phenotypic assay for detecting multiple nucleoside analogue reverse transcriptase inhibitor-resistant HIV-1 in plasma.
    Qari SH; Winters M; Vandamme AM; Merigan T; Heneine W
    Antivir Ther; 2002 Jun; 7(2):131-9. PubMed ID: 12212925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical characterization of a multi-drug resistant HIV-1 subtype AG reverse transcriptase: antagonism of AZT discrimination and excision pathways and sensitivity to RNase H inhibitors.
    Schneider A; Corona A; Spöring I; Jordan M; Buchholz B; Maccioni E; Di Santo R; Bodem J; Tramontano E; Wöhrl BM
    Nucleic Acids Res; 2016 Mar; 44(5):2310-22. PubMed ID: 26850643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced binding of azidothymidine-resistant human immunodeficiency virus 1 reverse transcriptase to the 3'-azido-3'-deoxythymidine 5'-monophosphate-terminated primer.
    Canard B; Sarfati SR; Richardson CC
    J Biol Chem; 1998 Jun; 273(23):14596-604. PubMed ID: 9603976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenesis of the Glu-89 residue in human immunodeficiency virus type 1 (HIV-1) and HIV-2 reverse transcriptases: effects on nucleoside analog resistance.
    Song Q; Yang G; Goff SP; Prasad VR
    J Virol; 1992 Dec; 66(12):7568-71. PubMed ID: 1279207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-directed mutagenesis of human immunodeficiency virus type 1 reverse transcriptase at amino acid position 138.
    Pelemans H; Aertsen A; Van Laethem K; Vandamme AM; De Clercq E; Pérez-Pérez MJ; San-Félix A; Velázquez S; Camarasa MJ; Balzarini J
    Virology; 2001 Feb; 280(1):97-106. PubMed ID: 11162823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AZT resistance of simian foamy virus reverse transcriptase is based on the excision of AZTMP in the presence of ATP.
    Hartl MJ; Kretzschmar B; Frohn A; Nowrouzi A; Rethwilm A; Wöhrl BM
    Nucleic Acids Res; 2008 Feb; 36(3):1009-16. PubMed ID: 18096624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro enzymatic activity of human immunodeficiency virus type 1 reverse transcriptase mutants in the highly conserved YMDD amino acid motif correlates with the infectious potential of the proviral genome.
    Wakefield JK; Jablonski SA; Morrow CD
    J Virol; 1992 Nov; 66(11):6806-12. PubMed ID: 1383571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations within the RNase H domain of human immunodeficiency virus type 1 reverse transcriptase abolish virus infectivity.
    Tisdale M; Schulze T; Larder BA; Moelling K
    J Gen Virol; 1991 Jan; 72 ( Pt 1)():59-66. PubMed ID: 1703563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.